Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neurogene (NGNE) Other Non Operating Income (2018 - 2025)

Neurogene's Other Non Operating Income history spans 6 years, with the latest figure at $156000.0 for Q4 2025.

  • For Q4 2025, Other Non Operating Income rose 8.33% year-over-year to $156000.0; the TTM value through Dec 2025 reached $1.7 million, up 190.07%, while the annual FY2025 figure was $1.7 million, 190.07% up from the prior year.
  • Other Non Operating Income reached $156000.0 in Q4 2025 per NGNE's latest filing, up from $149000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $16.4 million in Q4 2023 to a low of $143000.0 in Q1 2024.
  • Average Other Non Operating Income over 3 years is $2.1 million, with a median of $148000.0 recorded in 2025.
  • Peak YoY movement for Other Non Operating Income: plummeted 99.12% in 2024, then soared 741.67% in 2025.
  • A 3-year view of Other Non Operating Income shows it stood at $16.4 million in 2023, then tumbled by 99.12% to $144000.0 in 2024, then increased by 8.33% to $156000.0 in 2025.
  • Per Business Quant, the three most recent readings for NGNE's Other Non Operating Income are $156000.0 (Q4 2025), $149000.0 (Q3 2025), and $1.2 million (Q2 2025).